A startup company spun out of Johns Hopkins says it’s been able to slow the progression of Parkinson’s disease in mice models — and with a fresh infusion of cash, the company is taking the program into human trials.
{iframe}https://endpts.com/armed-with-36m-a-round-johns-hopkins-spinout-neuraly-heads-to-phi-parkinsons-trial/{/iframe}